Answer:
D) Silent mutation on second codon, third amino acid changed from ILE to ASN.
Explanation:
Silent mutations are usually point mutation where you change one nucleotide. Since, the nucleotide changed is the third position, it does not affect the protein being manufactured (it will still put the amino acid Ala) [look up the codon redundancy on youtub.e to understand how awesome nature is!]
On the other hand, the other mutation introduced is Missense mutation where a different Amino acid is added due to change in codon (goes from ILE to ASN).
The right answer is: C) Iruptive Growth. For their growth is never stable.
The species will begin to die off to fall below the carrying capasity
I think it’s C because if you’re allergic to one cillian than you’re allergic to all of them
Sorry if this is wrong
Human monoclonal antibody (mAbs) are emerging in the field of cancer therapy and have become an increasing proportion of new drugs that are recently approved. Although there are some methods to obtain antigen-specific mAbs from human B cells, it is generally impossible to directly immunize human beings with antigens of interest. For example, for infectious agents, those approaches are largely restricted. To solve these obstacles, two main approaches have been developed; either by humanizing antigen-specific antibodies from small experimental animals (which is laborious due to the great genetic differences from humans) or rely on the in vitro selection of antigen-specific binders from human antibody repertoires. However, the human mAbs developed by these methods are usually with low affinity.
We are now coming up with a much better idea that is humanizing non-human primates mAbs instead of murine mAbs. Due to the close genetic relationship with humans, immunized NHPs have more potential to be isolated with high affinity antibody to human target than other experimental species, such as mouse, rat and rabbit. In addition, with appropriate method, NHP antibodies are much<span> easier to be humanized</span> without any loss of affinity compared to widely used murine antibodies.
Resource: http://www.creative-biolabs.com/High-Affi-TM-Human-Antibody-Discovery.html